MedicalResearch.com Interview with: Simon Maltais MD PhD
Vanderbilt University Medical Center
Division of Cardiovascular Surgery
1215 21st Ave S, MCE 5th Flr
Nashville, TN 37232-8808.
MedicalResearch.com: What did your study evaluate and why is this important?
Answer: We performed a rigorous, retrospective review of the Scientific Registry of Transplant Recipients (SRTR) data base to evaluate donor, recipient, and technical characteristics associated with graft survival in patients undergoing mechanical circulatory support (MCS) device explantation at the time of heart transplantation surgery.
Donor and recipient characteristics has been well described in the medical literature for routine heart transplantation, however these characteristics in patients who were supported with a long term MCS device at the time of heart transplant was not known. Additionally, due to chronic donor heart shortages, an increasing number of patients with advanced heart failure are being bridged with MSC devices until a suitable donor heart can be obtained.
MedicalResearch.com Interview with Dr. Pietro Manuel Ferraro
Division of Nephrology–Renal Program, Department of Internal Medicine and Medical Specialties, Columbus-Gemelli Hospital, Rome, Italy
MedicalResearch.com: What are the main findings of the study?
Dr. Ferraro: We analyzed three large cohorts over time to see if those with prevalent or incident kidney stones might have a higher risk of developing coronary heart disease (fatal or non fatal myocardial infarction or the need for coronary revascularization). The cohorts consisted of over 200,000 participants without any prior history of coronary heart disease. After a median follow-up of over 8 years, we observed that women affected with stones seem to have a greater risk of developing coronary heart disease independent of a number of other known cardiovascular risk factors such as diabetes or high blood pressure. We did not observe a significant association among men.
MedicalResearch.com Interview with:
Susan Matulevicius, MD, MSCS
Department of Medicine, The University of Texas Southwestern Medical Center, Dallas
MedicalResearch.com: What are the main findings of the study?
Dr. Matulevicius: In our cohort of 535 transthoracic echocardiograms performed at a single academic medical center, we found that the majority (92%) of echocardiograms were appropriate by the 2011 Appropriate Use Criteria; however, only 1 in 3 echocardiograms lead to an active change in patient care while 1 in 5 resulted in no appreciable change in patient care.
Interview with: Dr Nicholas D Gollop BSc (Hons) MB BCh
Norfolk and Norwich University Hospital,
Norwich, NR4 7UY
Norfolk, United Kingdom
MedicalResearch.com: What are the main findings of the study?
We completed a best evidence topic in interventional cardiac surgery to investigate the significance of elevated markers of cardiac damage following percutaneous coronary intervention (PCI).
We compared the clinical and prognostic relevance of the elevation of creatinine kinase-myocardial band (CK-MB) and cardiac troponin (cTn) levels during peri-procedural period and post-procedural period, respectively, following an emergency or elective PCI.
We found in excess of 390 papers after a systematic literature search, of which 10 represented the best evidence to answer the clinical question. From the best evidence available we showed that the monitoring of cardiac biomarkers following PCI can provide important clinical information about the health of the myocardium, as well as prognostic information on short to mid-term outcomes of mortality up to 3 years.
MedicalResearch.com Interview with Dr. Kumar Dharmarajan MD MBAMedicalResearch.com eInterview with Luis Beck-da-Silva, MD, ScD Cardiology Division, Heart Failure Clinic Hospital de Clínicas de Porto Alegre Rua Ramiro Barcelos, 2350 Sala 2060 Porto Alegre, RS 90035-903, Brazil MedicalResearch.com: What are the main findings of the study? Answer: The actual take home message is that fluid and sodium restriction may not be of any benefit...
| MedicalResearch.com eInterview with: Dugald Seely ND, MSc, FABNO Founder & Executive Director; Ottawa Integrative Cancer Centre Director; Research & Clinical Epidemiology; Canadian College of Naturopathic Medicine Affiliate Investigator; Ottawa Hospital Research Institute 29 Bayswater Ave Ottawa, ON, K1Y 2E5 www.oicc.ca |
MedicalResearch.com eInterview with Satya Krishna Ramachandran MD FRCA Director, Quality Assurance Department of Anesthesiology University of Michigan MedicalResearch.com: What are the main findings of the study? Answer: Background: A cardiac arrest is a life-threatening condition where the heart has stopped beating. This remains one of the biggest fears of patients undergoing anesthesia and surgery. This is a...
The National Institutes of Health has launched two multi-site clinical trials to evaluate treatments for out-of-hospital cardiac arrest. One will compare continuous chest compressions (CCC) combined with pause- free rescue breathing to standard cardiopulmonary resuscitation (CPR), which includes a combination of chest compressions and pauses for rescue breathing. The other...
Released: 10/10/2011 9:00 AM Source: Thomas Jefferson University Newswise — (PHILADELPHIA) – Beth Moore can now keep up with her children. The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more severe, turning into bronchitis and eventually asthma, diminishing her...